vimarsana.com
Home
Live Updates
Noxopharm Ltd reveals new Sofra™ drug reduces inflamm
Noxopharm Ltd reveals new Sofra™ drug reduces inflamm
Noxopharm Ltd reveals new Sofra™ drug reduces inflammation
A new pre-clinical product candidate from Noxopharm Ltd (ASX:NOX, OTC:NOXOF)’s Sofra™ technology platform, known as SOF-XX, has shown to be effective...
Related Keywords
Australia ,
Seoul ,
Soult Ukpyolsi ,
South Korea ,
Gisela Mautner ,
Michael Gantier ,
Hudson Institute ,
Noxopharm Ltd ,
Melbourne Hudson Institute Of Medical Research ,
International Congress On Systemic Lupus Erythematosus ,
Medical Research ,
International Congress ,
Systemic Lupus Erythematosus ,
Associate Professor Michael Gantier ,